SSTR2 and metastatic neoplasm: SSTR2 and norepinephrine transporter overexpression plays a crucial role in the uptake of radiolabeled SSAs (177Lu or 90Y-SSAs) and of 131I-MIBG, which makes them a target for the therapy of metastatic tumors [121].